Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Calorie restriction extends lifespan and produces a metabolic profile desirable for treating diseases of ageing such as type 2 diabetes. SIRT1, an NAD+-dependent deacetylase, is a principal modulator of pathways downstream of calorie restriction that produce beneficial effects on glucose homeostasis and insulin sensitivity. Resveratrol, a polyphenolic SIRT1 activator, mimics the anti-ageing effects of calorie restriction in lower organisms and in mice fed a high-fat diet ameliorates insulin resistance, increases mitochondrial content, and prolongs survival. Here we describe the identification and characterization of small molecule activators of SIRT1 that are structurally unrelated to, and 1,000-fold more potent than, resveratrol. These compounds bind to the SIRT1 enzyme-peptide substrate complex at an allosteric site amino-terminal to the catalytic domain and lower the Michaelis constant for acetylated substrates. In diet-induced obese and genetically obese mice, these compounds improve insulin sensitivity, lower plasma glucose, and increase mitochondrial capacity. In Zucker fa/fa rats, hyperinsulinaemic-euglycaemic clamp studies demonstrate that SIRT1 activators improve whole-body glucose homeostasis and insulin sensitivity in adipose tissue, skeletal muscle and liver. Thus, SIRT1 activation is a promising new therapeutic approach for treating diseases of ageing such as type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, we show that recently developed SIRT1 activators, which are effective in improving energy homeostasis and decreasing hepatosteatosis in mouse models (Milne et al. 2007;Feige et al. 2008), also increase ubiquitination and proteasomal targeting of SREBP-1a, resulting in decreased SREBP-1 nuclear levels and target gene expression.”
From Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP (2010) · cites this paper as Milne et al. 2007
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent studies have reported the identification of potent SIRT1-activating compounds, and showed that such SIRT1 activators could significantly ameliorate insulin resistance and improve energy homeostasis in mouse diet-induced obesity models (Milne et al. 2007).”
From Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP (2010) · cites this paper as Milne et al. 2007
In the citing paper
“In contrast to these negative regulators of insulin action, SIRT1 appears to be a positive regulator of insulin sensitivity (43,44).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [43]
In the citing paper
“Additionally, the non-naturally occurring sirtuin-activating compound, SRT1720, has enhanced insulin sensitivity and oxidative metabolism in animal models of obesity, in part, by improving mitochondrial oxidative capacity231.”
From Mitochondrial and metabolic dysfunction in ageing and age-related diseases (2022) · cites this paper as [231]
In the citing paper
“Other related small molecules are more potent than resveratrol to enhance the action of SIRT1 on substrates for deacetylation (218). These compounds also improve insulin sensitivity in obese rodents (218).”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [218]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Self-citationLagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Self-citationSmall molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Self-citationTranscriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
Kaeberlein, M., McVey, M., & Guarente, L. (1999) · Genes & Development · doi:10.1101/gad.13.19.2570 · Cited by 2,253
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase
Cohen, H. Y., Miller, C., Bitterman, K. J., Wall, N. R., Hekking, B., Kessler, B., Howitz, K. T., Gorospe, M., de Cabo, R., & Sinclair, D. A. (2004) · Science · doi:10.1126/science.1099196 · Cited by 1,924
Self-citationSirtuin activators mimic caloric restriction and delay ageing in metazoans
Wood, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M., & Sinclair, D. (2004) · Nature · doi:10.1038/nature02789 · Cited by 1,868
Self-citation
Research works printed but not linked: 1
- Banks A, et al. Overexpression of the Sirtuin SIRT1 increases insulin sensitivity in aging mice. Diabetes. 2007;56(S1):0234-OR. [Google Scholar]
Cited by
Items 901–1,000 of 1,004
DNA methylation and hepatic insulin resistance and steatosis
Sookoian, S. C., & Pirola, C. J. (2012) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3283546f9f · Cited by 34
“Unau 1363-1950 2012 Wolters Kluwer Health | Lippincott Williams & Wilk showed improvements in insulin sensitivity, plasma glucose levels, and increased mitochondrial capacity in an experimental model of insulin resistance [25].”
BackgroundInteractomic and Pharmacological Insights on Human Sirt-1
Sharma, A., Gautam, V., Costantini, S., Paladino, A., & Colonna, G. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00040 · Cited by 38
“In particular, Milne et al. (2007) showed that three synthetic activators, namely SRT1460, SRT1720, and SRT2183, are Sirt-1 activators better than the natural resveratrol because EC values of these three synthetic activators are lower than the natural ones.”
BackgroundMethodResultInfluentialRole of Sirtuins in Maintenance of Genomic Stability: Relevance to Cancer and Healthy Aging
Wu, X., Neng, C., Fenech, M. F., & Wang, X. (2016) · DNA and Cell Biology · doi:10.1089/dna.2016.3280 · Cited by 34
“Although its full spectrum of effects remains to be determined, SRT1720 would not ostensibly share off-target effects of resveratrol and is more effective, inducing 750% SIRT1 activity at 10 m M (Milne et al. , 2007).”
Alkylresorcinols activate SIRT1 and delay ageing in Drosophila melanogaster
Kayashima, Y., Katayanagi, Y., Tanaka, K., Fukutomi, R., Hiramoto, S., & Imai, S. (2017) · Scientific Reports · doi:10.1038/srep43679 · Cited by 35
Tang, Q., Lu, M., Xu, B., Wang, Y., Lu, S.-F., Yu, Z. H., Jing, X., & Yuan, J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.607113 · Cited by 41
“Sirtuin 1 (SIRT-1), an NAD+-dependent deacetylase, plays a vital role in regulating the browning program in WAT, which is also a principal modulator of pathways downstream of calorie restriction (17), and a key mediator of AMP-activated kinase (AMPK) action on PGC-1a transcriptional activity, the expression of mitocho…”
BackgroundRelationship Between Redox Status and Cell Fate in Immunity and Autoimmunity
Ortona, E., Maselli, A., Delunardo, F., Colasanti, T., Giovannetti, A., & Pierdominici, M. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5752 · Cited by 35
“It has been reported that resveratrol can inhibit several experimental autoimmune diseases, including diabetes, encephalomyelitis, and colitis (70, 113, 150).”
Sirtuin Deacetylases as Therapeutic Targets in the Nervous System
Langley, B. C., & Sauve, A. A. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0214-5 · Cited by 34
“Compounds of independent structure from resveratrol, discovered by similar assays to that which obtained resveratrol as a STAC, have also provided impressive insulin sensitizing effects and positive health outcome in high fat diet challenged rodents [120].”
Gestational diabetes induces alterations of sirtuins in fetal endothelial cells
Gui, J., Potthast, A. B., Rohrbach, A., Borns, K., Das, A. M., & von Versen‐Höynck, F. (2015) · Pediatric Research · doi:10.1038/pr.2015.269 · Cited by 32
Yu, L., Liu, X., Li, X., Yuan, Z., Yang, H., Zhang, L., & Jiang, Z. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.10.016 · Cited by 36
“In fact, resveratrol is not a specific activator of SIRT1 because it can activate other signalling pathways (Smith et al., 2009; Milne et al., 2007).”
BackgroundSelf-citationIdentification of Promiscuous Small Molecule Activators in High-Throughput Enzyme Activation Screens
Goode, D. R., Totten, R. K., Heeres, J. T., & Hergenrother, P. J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701583b · Cited by 33
Dammarane Triterpenes as Potential SIRT1 Activators from the Leaves of Panax ginseng
Yang, J.-L., Ha, T. K. Q., Dhodary, B., Kim, K.-H., Park, J., Lee, C., Kim, Y.-C., & Oh, W. K. (2014) · Journal of Natural Products · doi:10.1021/np5002303 · Cited by 36
Liu, X., Wang, K., Zhou, J., Sullivan, M. A., Liu, Y., Gilbert, R. G., & Deng, B. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.116435 · Cited by 34
Jiang, T., Yang, W., Zhang, H., Song, Z., Liu, T., & Lv, X. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00596 · Cited by 33
“Numerous studies found that SIRT1 expression was significantly decreased in the diabetic state and that overexpression of SIRT1 produced beneficial effects on glucose homeostasis (Milne et al., 2007).”
BackgroundEriau, E., Paillet, J., Kroemer, G., & Pol, J. G. (2021) · Cancers · doi:10.3390/cancers13061260 · Cited by 33
Zamora, M., Pardo, R., & Villena, J. A. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.06.032 · Cited by 34
Dual role of Zn2+ in maintaining structural integrity and suppressing deacetylase activity of SIRT1
Chen, L., Yu, F., Zhou, Y., Zhu, W., Shen, X., Chen, K., Jiang, H., & Liu, D. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2009.10.021 · Cited by 36
SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells
Lahusen, T. J., & Deng, C. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0584 · Cited by 34
“Previous reports have shown that SRT1720 exerts biologic effects through the sirtuin deacetylase SIRT1 (4, 20).”
BackgroundZhang, N., Li, Z., Xu, K., Wang, Y., & Wang, Z. (2016) · Biological & Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00085 · Cited by 32
Wang, Y., Zhao, R., Wu, C., Liang, X., He, L., Wang, L., & Wang, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1111320 · Cited by 36
“…Obese mice model Minor et al. (2011) 11 Strigolactone analogue GR24 Rat L6 skeletal muscle cell line Modi et al. (2017) 12 SIRT1460 Obese mice model Milne et al. (2007) 13 SRT2183 sirt1−/− mice model Gurt et al. (2015) 14 A03 Alzheimer’s disease mouse model Campagna et al. (2018) 15 MHY2233 db/db…”
BackgroundSingh, P., Mandal, T., Balsubramanian, N., Viaene, T., Leedahl, T. S., Sule, N., Cook, G. R., & Srivastava, D. K. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.07.080 · Cited by 35
An improved fluorogenic assay for SIRT1, SIRT2, and SIRT3
Chiang, Y., & Lin, H. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob02609a · Cited by 33
Hegedűs, C., Muresan, M. E., Badale, A., Bombicz, M., Varga, B., Szilágyi, A., Sinka, D., Bácskay, I., Popoviciu, M. S., Magyar, I., et al. (2020) · Molecules · doi:10.3390/molecules25112541 · Cited by 39
“reported that reduced SIRT1 can lead to hepatic insulin resistance [47,48], and SIRT1 activation alleviates hepatic insulin resistance in obesity [49].”
BackgroundAvilkina, V., Chauveau, C., & Mhenni, O. G. (2021) · Bone · doi:10.1016/j.bone.2021.116232 · Cited by 34
Mahajan, S. S., Leko, V., Simon, J. A., & Bedalov, A. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-21631-2_11 · Cited by 36
“did not reproduce glucose-lowering activity or improvements in mitochondrial capacity [57] that were shown in the initial report [56].”
BackgroundAnti-Aging Medicine: Molecular Basis for Endothelial Cell-Targeted Strategies – A Mini-Review
Camici, G. G., Shi, Y., Cosentino, F., Francia, P., & Lüscher, T. F. (2010) · Gerontology · doi:10.1159/000314227 · Cited by 34
Shah, Z. H., Ahmed, S. U., Ford, J. R., Allison, S. J., Knight, J. R. P., & Milner, J. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06448-11 · Cited by 35
“The SIRT1- 2/9 coding sequence lacks the SIRT1 core catalytic deacetylatase domain, which stretches from codon 240 in exon 3 to codon 664 in exon 8 of SIRT1 (36): exon2-exon 9 splicing removed this domain (Fig.”
BackgroundLiu, X., Wang, N., Zhu, Y., Yang, Y., Chen, X., Fan, S., Chen, Q., Zhou, H., & Zheng, J. (2016) · Mediators of Inflammation · doi:10.1155/2016/6152713 · Cited by 34
Emerging candidate treatment strategies for Hutchinson-Gilford progeria syndrome
Strandgren, C., Revêchon, G., Sola-Carvajal, A., & Eriksson, M. (2017) · Biochemical Society Transactions · doi:10.1042/bst20170141 · Cited by 34
NO Targets SIRT1: A Novel Signaling Network in Endothelial Senescence
Potente, M., & Dimmeler, S. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.173682 · Cited by 34
Luo, X., Jia, R., Yao, Q., Xu, Y., Luo, Z., Luo, X., & Wang, N. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500714 · Cited by 30
The Emerging Role of SIRT7 in Glucose and Lipid Metabolism
Yamagata, K., Mizumoto, T., & Yoshizawa, T. (2023) · Cells · doi:10.3390/cells13010048 · Cited by 34
“SIRT1 activation by small-molecule activators improves insulin sensitivity and glucose homeostasis by enhancing fat oxidation in the liver, skeletal muscles, and BAT [69,115,116].”
BackgroundElmorsy, E. A., Elsisi, H. A., Alkhamiss, A. S., Alsoqih, N. S., Khodeir, M. M., Alsalloom, A. A., Almeman, A. A., Elghandour, S. R., Nadwa, E. H., Khalifa, A. K., et al. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107002 · Cited by 32
N-Modified lysine containing inhibitors for SIRT1 and SIRT2
Huhtiniemi, T., Suuronen, T., Lahtela-Kakkonen, M. K., Bruijn, T., Jääskeläinen, S., Poso, A., Salminen, A., Leppänen, J., & Jarho, E. M. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.06.035 · Cited by 37
Lifespan extension of rotifers by treatment with red algal extracts
Snare, D. J., Fields, A. M., Snell, T. W., & Kubanek, J. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.09.007 · Cited by 32
“…antioxidant effects among the life extending algal extracts or small molecule mixtures, our results indicate that efficacious small molecules do not neutralize ROS through direct reactions, and may instead activate protective pathways through signaling (e.g., Howitz et al. 2003; Milne et al. 2007).”
BackgroundIntegrating Epigenomics into the Understanding of Biomedical Insight
Han, Y., & He, X. (2016) · Bioinformatics and Biology Insights · doi:10.4137/bbi.s38427 · Cited by 32
“…nicotinamide adenine dinucleotide phosphate (NADP) level can activate the sirtuins to mimic the effect of caloric restriction on genome-wide gene expression, 89,90 so that it represents an epigenetic interventional path to prevent neurodegeneration, 91 type II diabetes, 92 cancer, 93 and aging.”
BackgroundMiao, L., Lin, Y., Pan, W.-J., Huang, X., Ge, X., Ren, M., Zhou, Q., & Liu, B. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061161 · Cited by 33
“Another mam-miR-214b target SIRT1, whose loss relates to glucose-stimulated insulin secretion and activation improves insulin sensitivity of type 2 diabetes [46,47], has been reported to be protective against high-fat diet-induced metabolic damage and thus may be explored as a therapeutic target for type 2 diabetes tr…”
BackgroundComparative proteomic study of dog and human saliva
Sanguansermsri, P., Jenkinson, H. F., Thanasak, J., Chairatvit, K., Roytrakul, S., Kittisenachai, S., Puengsurin, D., & Surarit, R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208317 · Cited by 35
“Sirtuin is an important protein related to cellular homeostasis such as carbohydrate, protein and lipid metabolism, aging and may play a role in type II diabetes pathogenesis [36,37].”
Sirt1 coordinates with ERα to regulate autophagy and adiposity
Tao, Z., Shi, L., Parke, J., Zheng, L., Gu, W. J., Dong, X. C., Liu, D., Wang, Z., Olumi, A. F., & Cheng, Z. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00438-8 · Cited by 33
Therapeutic Antiaging Strategies
Mishra, S. K., Balendra, V., Esposto, J., Obaid, A. A., Maccioni, R. B., Jha, N. K., Perry, G. L., Moustafa, M., Al-Shehri, M., Singh, M. P., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10102515 · Cited by 36
Rohrbach, S., Aslam, M., Niemann, B., & Schulz, R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12650 · Cited by 38
“Other SIRT activators A number of synthetic SIRT1-activating compounds (STACs), that are 1000 times more effective than resveratrol in vitro (Milne et al., 2007), such as SRT1720, SRT2104, SRT2183 and SRT2379, have been developed (Sirtis).”
BackgroundMcClure, J. M., Wierman, M. B., Maqani, N., & Smith, J. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.367524 · Cited by 33
“Sirtuin agonists include the red wine compound resveratrol (25) and other related polyphenol compounds called STACs (sirtuin-activating compounds), which activate the human SIRT1 enzyme by increasing the binding affinity of SIRT1 for its acetylated target protein (26), although the specificity of these compounds has b…”
BackgroundSelf-citationJeong, H. W., Cho, S. Y., Kim, S., Shin, E. S., Kim, J. M., Song, M. J., Park, P. J., Sohn, J. H., Park, H., Seo, D.-B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040073 · Cited by 32
“mitochondrial function [23,25,26], activators of these enzymes could enhance mitochondrial biogenesis and exercise endurance.”
BackgroundModi, S., Yaluri, N., Kokkola, T., & Laakso, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-17840-x · Cited by 37
Oxidative Stress in Alzheimer’s Disease: The Shortcomings of Antioxidant Therapies
Pappolla, M. A., Martins, R. N., Poeggeler, B., Omar, R. A., & Perry, G. (2024) · Journal of Alzheimer's Disease · doi:10.3233/jad-240659 · Cited by 29
Barik, S. K., Sengupta, S., Arya, R., Kumar, S., Kim, J.-J., & Chaurasia, R. (2024) · Advances in Nutrition · doi:10.1016/j.advnut.2024.100346 · Cited by 43
Cross-talk between SIRT1 and endocrine factors: effects on energy homeostasis
Quiñones, M., Al–Massadi, O., Fernø, J., & Nogueiras, R. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.08.002 · Cited by 30
Gueguen, C., Palmier, B., Plotkine, M., Marchand‐Leroux, C., & Besson, V. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087367 · Cited by 33
“As there was no information on the passage of SRT1720 across the blood-brain barrier, it was directly administrated into the cerebrospinal fluid at a dose calculated from in vitro data showing 4 time SIRT1 activation [22].”
BackgroundMethodInfluentialChen, W., Fan, S., Xie, X., Xue, N., Jin, X., & Wang, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096056 · Cited by 29
“2 mM and 201% respectively) [23].”
A patent review of sirtuin activators: an update
Villalba, J. M., de Cabo, R., & Alcain, F. J. (2012) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.669374 · Cited by 32
“[87], SRT1720 neither lowered plasma glucose nor improved mitochondrial capacity in mice fed a high-fat diet, which is in sharp contrast with data reported previously [69,75].”
BackgroundResultInfluentialSRT1720 retards renal fibrosis via inhibition of HIF1A/GLUT1 in diabetic nephropathy
Han, W., Wang, C., Yang, Z., Mu, L., Wu, M. T., Chen, N., Du, C., Duan, H., & Shi, Y. (2019) · Journal of Endocrinology · doi:10.1530/joe-18-0536 · Cited by 31
Poljšak, B., Kovač, V., & Milisav, I. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8819627 · Cited by 36
“Disrupted circadian rhythms were reported in many pathological conditions including cardiovascular diseases, diabetes, cancer, and accelerated ageing [134, 135].”
BackgroundA mini-review on Sirtuin activity assays
Li, Y., Liu, T., Liao, S., Li, Y., Lan, Y., Wang, A., Wang, Y., & He, B. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.09.172 · Cited by 34
Selectivity hot-spots of sirtuin catalytic cores
Parenti, M. D., Bruzzone, S., Nencioni, A., & Río, A. D. (2015) · Molecular BioSystems · doi:10.1039/c5mb00205b · Cited by 30
Gul, S., & Gribbon, P. M. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2010.495748 · Cited by 30
“Further in vivo studies on resveratrol in mice appeared to reinforce the in vitro findings, with increased protection against obesity and diabetes [55,56].”
BackgroundSirtuin biology and relevance to diabetes treatment
Dong, X. C. (2012) · Diabetes Management · doi:10.2217/dmt.12.16 · Cited by 30
Glucagon-Induced Acetylation of Energy-Sensing Factors in Control of Hepatic Metabolism
Zhang, L., Yao, W., Xia, J., Wang, T., & Huang, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081885 · Cited by 32
Resveratrol and its impact on aging and thyroid function.
Duntas, L. H. (2011) · PubMed · doi:10.3275/7926 · Cited by 29
Emerging mitochondrial signaling mechanisms in physiology, aging processes, and as drug targets
Lakshminarasimhan, M., & Steegborn, C. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.08.024 · Cited by 30
“Resveratrol can induce effects similar to CR, including Sirtuin-mediated lifespan extension and protection against diseases such as insulin resistance (Milne et al., 2007).”
Fukaya, M., Tamura, Y., Chiba, Y., Tanioka, T., Mao, J., Inoue, Y., Yamada, M., Waeber, C., Ido-Kitamura, Y., Kitamura, T., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.11.024 · Cited by 34
“It should be noted that activation of Sirt1 improves insulin sensitivity in rodent models of obesity-induced diabetes [27,28], as well as promotes insulin secretion and b-cell survival in cell culture [17].”
Milbank, E., Martínez, M. C., & Andriantsitohaina, R. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.11.002 · Cited by 33
“At first described as an actor promoting longevity in yeast species such as Saccharomyces cerevisae through its homolog Sir2, Sirt1 is implicated in energy balance regulation (Milne et al., 2007).”
BackgroundKawaguchi, M., Ikegawa, S., Ieda, N., & Nakagawa, H. (2016) · ChemBioChem · doi:10.1002/cbic.201600374 · Cited by 29
Lim, H., Park, J., Kim, H., Kang, J., Jeong, M., Youn, D., Jung, Y., Kim, Y.-I., Kim, H., Ahn, K. S., et al. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00476 · Cited by 31
“Activation of the NAD+-dependent deacetylase SIRT1 by therapeutic small molecules, caloric restriction or exercise promotes mitochondrial biogenesis and activities (Milne et al., 2007), raising the possibility that SIRT1 can regulate BAT functions.”
BackgroundTranscriptional Regulation of Metabolism by SIRT1 and SIRT7
Yamagata, K., & Yoshizawa, T. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.07.009 · Cited by 31
Effects of Moringa oleifera Leaves Extract on High Glucose-Induced Metabolic Changes in HepG2 Cells
Gutiérrez, J. A. S., Valdez-Solana, M. A., Forbes-Hernández, T. Y., Avitia-Domínguez, C. I., García-Vargas, G. G., Salas-Pacheco, J. M., Flores-Herrera, Ó., Téllez‐Valencia, A., Battino, M. A., & Sierra‐Campos, E. (2018) · Biology · doi:10.3390/biology7030037 · Cited by 32
“On the other hand, metformin can increase the expression of SIRT1 and reduce the expression of UCP2, with negative correlation between the expression of SIRT1 and UCP2 [80].”
BackgroundInfluentialImpact of natural curcumin on the progression of experimental periodontitis in diabetic rats
Pimentel, S. P., Casati, M. Z., Ribeiro, F. V., Corrêa, M. G., Franck, F. C., Benatti, B. B., & Cirano, F. R. (2019) · Journal of Periodontal Research · doi:10.1111/jre.12683 · Cited by 29
Zhang, J., Chen, Y., Liu, C., Li, L., & Li, P. (2020) · Journal of Diabetes Research · doi:10.1155/2020/1080152 · Cited by 31
“In Zucker’s fa/fa obese rat model, SIRT1 activating factor (SRT1720) could improve type 2 diabetes by increasing systemic insulin sensitivity and mitochondrial capacity, as well as reducing hepatic glucose production [37].”
BackgroundChiba, T., Tsuchiya, T., Komatsu, T., Mori, R., Hayashi, H., & Shimokawa, I. (2010) · Current Genomics · doi:10.2174/138920210793360934 · Cited by 29
“Using obese mice, they also showed that SRT1720 improved insulin sensitivity, lowered blood glucose, and increased mitochondrial capacity [57].”
BackgroundInfluentialXu, J., Kitada, M., & Koya, D. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165756 · Cited by 32
Phenotypic Screening in C. elegans as a Tool for the Discovery of New Geroprotective Drugs
Bulterijs, S., & Braeckman, B. P. (2020) · Pharmaceuticals · doi:10.3390/ph13080164 · Cited by 33
“Next, a high-throughput (290,000 compounds) target-based screen for SIRT-1 activators was conducted that led to the identification of various SIRT1 activators with a potency of over 1000-times that of resveratrol [91].”
BackgroundSirtuins, a key regulator of ageing and age-related neurodegenerative diseases
Bhatt, V., & Tiwari, A. K. (2023) · International Journal of Neuroscience · doi:10.1080/00207454.2022.2057849 · Cited by 28
“Further, it was shown that resveratrol improves the mitochondrial function and insulin sensitivity [209, 225, 229, 239].”
BackgroundSchleit, J., Wasko, B. M., & Kaeberlein, M. R. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.07.038 · Cited by 30
“Sirtuin activators, TOR inhibitors, and AMPK activators have all been proposed as CR mimetics – pharmacological agents that mimic the effects of CR on longevity and health without requiring reduced nutrient intake [19–23].”
BackgroundOmar, M. A., Frey, W. U., Conrad, J., & Beifuß, U. (2014) · The Journal of Organic Chemistry · doi:10.1021/jo501980w · Cited by 27
Uncoupling conformational states from activity in an allosteric enzyme
Pisco, J. P., de Chiara, C., Pacholarz, K. J., Garza-Garcı́a, A., Ogrodowicz, R. W., Walker, P. A., Barran, P. E., Smerdon, S. J., & de Carvalho, L. P. S. (2017) · Nature Communications · doi:10.1038/s41467-017-00224-0 · Cited by 27
TRB3 stimulates SIRT1 degradation and induces insulin resistance by lipotoxicity via COP1
Ren, X., Chen, N., Chen, Y., Liu, W., & Hu, Y. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.05.009 · Cited by 29
Zhang, M., Lü, P., Terada, T., Sui, M., Furuta, H., Iida, K., Katayama, Y., Lü, Y., Okamoto, K., Suzuki, M., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01705-1 · Cited by 34
Epigenetic enzymes: A role in aging and prospects for pharmacological targeting
PASYUKOVA, E. G., Symonenko, A. V., Rybina, O. Y., & Vaiserman, A. M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101312 · Cited by 29
Post-translational lysine ac(et)ylation in health, ageing and disease
Blasl, A., Schulze, S., Qin, C., Graf, L. G., Vogt, R., & Lammers, M. (2021) · Biological Chemistry · doi:10.1515/hsz-2021-0139 · Cited by 31
“Experimental data and structural modeling suggested, that AROS binds to the NTR resulting in a more compact conformation that is transmitted to the active site modulating SIRT1 activity (Autiero et al. 2008; Lakshminarasimhan et al. 2013; Milne et al. 2007).”
BackgroundLee, I., Lin, H., Huang, T., Tseng, C., Cheng, H.-T., Huang, W., & Cheng, C. (2022) · Antioxidants · doi:10.3390/antiox11050835 · Cited by 33
Pulla, V. K., Alvala, M., Sriram, D. S., Viswanadha, S., Sriram, D., & Yogeeswari, P. (2014) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2014.06.005 · Cited by 28
Advances in Label-Free Screening Approaches for Studying Sirtuin-Mediated Deacetylation
Rye, P. T., Frick, L. E., Özbal, C. C., & LaMarr, W. A. (2011) · SLAS DISCOVERY · doi:10.1177/1087057111420291 · Cited by 29
Mohammad, G., Abdelaziz, G. M., Siddiquei, M. M., Ahmad, A., Hertogh, G. D., & El‐Asrar, A. M. A. (2019) · Current Eye Research · doi:10.1080/02713683.2019.1625406 · Cited by 30
“Small molecule activators of SIRT1 that are structurally unrelated to resveratrol, but 1000-fold more potent than resveratrol were identified.(66) The compound named SRT1720 was the most effective, stimulated 750% SIRT1 activity at 10 μM and binds and activates the enzyme at the same molecular site as resveratrol.”
BackgroundDiverse actions of sirtuin-1 on ovulatory genes and cell death pathways in human granulosa cells
Sapuleni, J., Szymańska, M., & Meidan, R. (2022) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-022-00970-x · Cited by 28
“Consequently, specific and more potent synthetic activators of SIRT1 such as SRT1720 and SRT2104 were developed [27, 28].”
BackgroundChang, M., Xiao, J., Wang, Y., Yan, Y.-L., Yang, J. H., & Wang, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050291 · Cited by 28
“SIRT1 is considered to be a possible target for the treament of type 2 diabetes and metabolic syndrome [45,46].”
Gomes, P., Leal, H., Mendes, A. F., Reis, F., & Cavadas, C. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.09.003 · Cited by 28
Yang, Y., Li, Z., Guo, J., & Xu, Y. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165723 · Cited by 29
Tasinov, O., Dincheva, I. N., Badjakov, I. K., Kiselova-Kaneva, Y. D., Galunska, B. T., Nogueiras, R., & Ivanova, D. G. (2021) · Plants · doi:10.3390/plants10112446 · Cited by 29
Ribeiro, R. F. N., Pereira, D., de Almeida, L. P., Silva, M. M., & Cavadas, C. (2022) · Aging Clinical and Experimental Research · doi:10.1007/s40520-022-02257-y · Cited by 27
The roles of sirtuins in ferroptosis
Zeng, J., Guo, J., Huang, S., Cheng, Y., Luo, F., Xu, X., Chen, R., Ma, G., & Wang, Y. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1131201 · Cited by 34
Yang, S., Shen, W., Hu, J., Cai, S., Zhang, C., Jin, S., Guan, X., Wu, J., Wu, Y., & Cui, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1162211 · Cited by 33
Xiao, C. F., Tao, L., Sun, H. Y., Wei, W., Chen, Y., Fu, L., & Zou, Y. (2010) · Chinese Chemical Letters · doi:10.1016/j.cclet.2010.04.034 · Cited by 26
Cheng, Z., Schmelz, E. M., Liu, D., & Hulver, M. W. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300747 · Cited by 30
Yang, J., Wang, N., Zhu, Y. T., & Feng, P. (2011) · Archives of Medical Research · doi:10.1016/j.arcmed.2011.07.005 · Cited by 27
Svensson, K., Schnyder, S., Albert, V., Cardel, B., Quagliata, L., Terracciano, L., & Handschin, C. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.590653 · Cited by 26
“Because SRT is an activator of SIRT1 (10), which can deacetylate and thereby activate PGC-1 (17), we next determined the acetylation status of PGC-1 in the liver of control and SRT-treated animals.”
BackgroundThe Regulation of Insulin-Stimulated Cardiac Glucose Transport via Protein Acetylation
Renguet, E., Bultot, L., Beauloye, C., Horman, S., & Bertrand, L. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00070 · Cited by 26
“This was associated with a better glucose disposable rate, reflecting an improvement of glucose uptake in muscle (29, 30).”
BackgroundPan, S., Cui, Y., Fu, Z., Zhang, L., & Hua, X. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.10.013 · Cited by 27
SIRT1 accelerates the progression of activity-based anorexia
Robinette, T. M., Nicholatos, J. W., Francisco, A. B., Brooks, K. E., Diao, R. Y., Sorbi, S., Ricca, V., Nacmias, B., Brieño‐Enríquez, M. A., & Libert, S. (2020) · Nature Communications · doi:10.1038/s41467-020-16348-9 · Cited by 28
Celecoxib Sensitizes Staphylococcus aureus to Antibiotics in Macrophages by Modulating SIRT1
Annamanedi, M., & Kalle, A. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099285 · Cited by 25
“Furthermore, other known activators of SIRT1 (SRT1720, resveratrol) are also shown to bind to Nterminal SIRT1 [37,38] and thus our results are also in accordance with these studies implying activation of SIRT1 by celecoxib.”
ResultActivators of Sirtuin-1 and their Involvement in Cardioprotection
Granchi, C., & Minutolo, F. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180214115438 · Cited by 25
The depot-specific and essential roles of CBP/p300 in regulating adipose plasticity
Namwanje, M., Liu, L., Chan, M., Aaron, N., Kraakman, M. J., & Qiang, L. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0361 · Cited by 25
Sirtuins in Multiple Sclerosis: The crossroad of neurodegeneration, autoimmunity and metabolism
Foolad, F., Khodagholi, F., & Javan, M. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.06.004 · Cited by 28
Metadata
- Authors
- Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P., Smith, J. J., Gagne, D. J., Jin, L., Boss, O., Perni, R. B., Vu, C. B., Bemis, J. E., Xie, R., Disch, J. S., Ng, P. Y., Nunes, J. J., Lynch, A. V., Yang, H., Galonek, H., Israelian, K., Choy, W., Iffland, A., Lavu, S., Medvedik, O., Sinclair, D. A., Olefsky, J. M., Jirousek, M. R., Elliott, P. J., & Westphal, C. H.
- Affiliations
- University of California San Diego (US)
- Harvard University (US)
- Corresponding author
- Westphal, Christoph H.
- ORCID
- Venue
- Nature
- Published
- 2007-11-29
- Volume
- 450
- Issue
- 7170
- Pages
- 712-716
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2753457
- OpenAlex
- W2116350182
- Cited by
- 1,707
- References
- 27
- Citations by year
- 2026: 38 · 2025: 43 · 2024: 55 · 2023: 55 · 2022: 68 · 2021: 100 · 2020: 80 · 2019: 75 · 2018: 82 · 2017: 69 · 2016: 92 · 2015: 89 · 2014: 110 · 2013: 119 · 2012: 126
- FWCI
- 55.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institute on Aging (P01AG027916, R01AG028730, R01AG019719)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- SIRT1, small molecule activators, type 2 diabetes, insulin resistance, caloric restriction mimetics, resveratrol, NAD+-dependent deacetylase, allosteric site, glucose homeostasis, mitochondrial function, obesity, aging, drug screening
- MeSH terms
- Resveratrol, Acetylation, Allosteric Site, Animals, Blood Glucose, Cell Line, Diabetes Mellitus, Type 2, Dietary Fats, Disease Models, Animal, Drosophila melanogaster, Heterocyclic Compounds, 4 or More Rings, Humans, Insulin, Male, Mitochondria, Rats, Zucker, Stilbenes, Rats, Sprague-Dawley, Catalytic Domain, Caloric Restriction, Sirtuins, Mice, Rats, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.